MERCER GLOBAL ADVISORS INC /ADV
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 853758
DENVER, CO
Position in VRTX
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$15,252,094
+$5,087,951 QoQ
Shares Held
30,705
+34.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#292
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $302,411,362 across 140 Biotechnology names. VRTX ranks #4 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
941,283 | $124,936,492 | |
| 2 | CAPR |
Capricor Therapeutics, Inc.
|
802,732 | $19,329,786 | |
| 3 | ORMP |
Oramed Pharmaceuticals Inc.
|
3,810,540 | $18,328,697 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
30,705 | $15,252,094 | |
| 5 | INCY |
Incyte Corp
|
116,207 | $13,173,225 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,126 | $12,549,366 | |
| 7 | EXEL |
Exelixis, Inc.
|
176,339 | $9,594,604 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
102,823 | $8,940,459 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,252,094 | 30,705 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $10,164,143 | 22,762 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,799,941 | 23,822 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $7,356,565 | 18,784 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,246,439 | 18,523 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,301,874 | 15,061 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,641,021 | 14,008 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,232,459 | 15,551 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,735,286 | 16,503 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,600,079 | 13,397 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,906,415 | 14,516 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $4,077,946 | 11,727 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,875,936 | 11,014 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,186,933 | 10,115 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,395,141 | 8,294 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,352,222 | 8,124 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,524,556 | 8,959 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,632,143 | 10,086 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,080,270 | 9,473 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,309,998 | 7,222 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,292,045 | 6,408 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,826,116 | 17,805 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $1,217,860 | 5,153 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,851,504 | 6,804 | Shares | Sole | 2020-12-10 | |
| 2020-06-30 | $1,775,826 | 6,117 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $345,027 | 1,450 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||